Telemedicine interventions can improve communication and connection between older patients and their providers , and improve glycemic control .
Summary A systematic review confirmed the efficacy and safety of metformin as first-line therapy of type 2 diabetes in the older adult , but multiple reports highlighted the risk for vitamin B12 deficiency .
R and omized controlled trials showed the efficacy and safety of antihyperglycemic agents in the elderly , including some with longer duration and lesser risk for hypoglycemia .
R and omized clinical trials showed cardiovascular protection with SGLT-2i ( empagliflozin , canagliflozin ) and GLP-1RA ( liraglutide , semaglutide ) .
Purpose of Review The current approach to diabetes in the elderly incorporates components from the comprehensive geriatric approach .
The most up date d guidelines from the American Diabetes Association reflect influence from the consensus made in 2012 with the American Geriatrics Society .
Notably , the framework included the evaluation for geriatric syndromes ( falls and urinary incontinence ) , functional and cognitive abilities .
The goal for this review is to provide an up date d summary of treatment strategies for community-dwelling older adults .
Recent Findings Findings on cardiovascular protection with sodium-glucose co-transporter 2 inhibitors ( SGLT-2i ) and some glucagon-like peptide 1 receptor agonists ( GLP-1RA ) support their use for older patients with diabetes .
Functional medicine concepts can offer additional adjuvant strategies to support the therapeutic interventions and management of diabetes in the elderly .
The most current guidelines recommend addressing for geriatric syndromes , physical and cognitive function in the elderly , in order to individualize targets and therapeutic strategies .
GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion.
AIMS The GERODIAB study is the first French multicentre , prospect i ve , observational study that aims , through a 5-year cohort follow-up , to evaluate the link between glycaemic control and morbidity/mortality of type 2 diabetic ( T2D ) patients aged 70 years and older . This first report describes the study population at inclusion . PATIENTS AND METHODS A total of 987 T2D autonomous patients , aged ≥70 years , were recruited between June 2009 and July 2010 at 56 investigator centres . Their general parameters , diabetes characteristics and st and ard geriatric parameters were recorded . RESULTS The patients ' mean age was 77±5 years , with 65.2 % aged 75 years or more . The mean BMI was close to 30 kg/m(2 ) . Hypertension was found in 89.7 % of patients , and 85.0 % had at least one cholesterol abnormality . The mean duration of the diabetes was around 18 years , and the mean HbA(1c ) level was about 7.5 % . During the previous six months , 33.6 % of patients had experienced one or several hypoglycaemias . Also , 26 % of patients presented with diabetic retinopathy , 37.3 % had a GFR<60 mL/min , 31.2 % had coronary insufficiency , 10.1 % had heart failure , 15.8 % had cerebrovascular involvement and 25.6 % had peripheral vascular disease of the lower extremities . In addition , 30.5 % of patients had orthostatic hypotension , 12.4 % had malnutrition and 28.8 % had cognitive impairment , all of which were often diagnosed at inclusion . Three-quarters of patients were taking an oral antidiabetic drug and nearly six in every 10 patients were using insulin . CONCLUSION This population can be considered representative of elderly , autonomous T2D patients , and its follow-up should clarify the link between glycaemic control and mortality/morbidity
Telemedicine interventions can improve communication and connection between older patients and their providers , and improve glycemic control .
Summary A systematic review confirmed the efficacy and safety of metformin as first-line therapy of type 2 diabetes in the older adult , but multiple reports highlighted the risk for vitamin B12 deficiency .
R and omized controlled trials showed the efficacy and safety of antihyperglycemic agents in the elderly , including some with longer duration and lesser risk for hypoglycemia .
R and omized clinical trials showed cardiovascular protection with SGLT-2i ( empagliflozin , canagliflozin ) and GLP-1RA ( liraglutide , semaglutide ) .
Purpose of Review The current approach to diabetes in the elderly incorporates components from the comprehensive geriatric approach .
The most up date d guidelines from the American Diabetes Association reflect influence from the consensus made in 2012 with the American Geriatrics Society .
Notably , the framework included the evaluation for geriatric syndromes ( falls and urinary incontinence ) , functional and cognitive abilities .
The goal for this review is to provide an up date d summary of treatment strategies for community-dwelling older adults .
Recent Findings Findings on cardiovascular protection with sodium-glucose co-transporter 2 inhibitors ( SGLT-2i ) and some glucagon-like peptide 1 receptor agonists ( GLP-1RA ) support their use for older patients with diabetes .
Functional medicine concepts can offer additional adjuvant strategies to support the therapeutic interventions and management of diabetes in the elderly .
The most current guidelines recommend addressing for geriatric syndromes , physical and cognitive function in the elderly , in order to individualize targets and therapeutic strategies .